Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-03-Speech-4-459-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110203.25.4-459-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"−
Today, tuberculosis is one of the examples of how inequality between peoples impacts on the area of health, given that this disease has been almost eliminated from the industrialised countries and is still spreading in other parts of the world. It is currently also important to remember that tuberculosis is one of the infections that take advantage of the condition of those who are seropositive or have AIDS, making it particularly serious in these cases. These issues are the reason for this motion for a resolution, which advocates the need for a large-scale vaccination campaign, with a view to achieving the sixth Millennium Development Goal after 2015, and in particular, to eradicating tuberculosis by 2050.
These worthy goals were also the reason why I voted in favour. Vaccines are an essential means of decisively combating tuberculosis, together with better testing for detection of infection that is reliable and low cost, as well as more effective diagnosis and treatment. This implies a major shift in the focus of research and an increase in sustainable funding. The EU, through the European Commission, should explore innovative funding channels, such as the establishment by the Member States and/or the Union of a financial guarantee to enable funding for the Tuberculosis Vaccine Initiative to be obtained from the European Investment Bank, with a view to guaranteeing finance and research in this area."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples